Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vittorio Rizzoli

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Leukemia & Lymphoma|December 11, 2007
Myeloma cells and bone marrow osteoblast interactions: role in the development of osteolytic lesions in multiple myelomaNicola Giuliani, Vittorio Rizzoli
Experimental Hematology|August 17, 2004
New insight in the mechanism of osteoclast activation and formation in multiple myeloma: focus on the receptor activator of NF-kappaB ligand (RANKL)Nicola Giuliani, Simona Colla, Vittorio Rizzoli
Hematology (Amsterdam, Netherlands)|March 15, 2005
Angiogenic switch in multiple myelomaNicola Giuliani, Simona Colla, Vittorio Rizzoli
Acta Bio-Medica : Atenei Parmensis|March 31, 2005
Update on the pathogenesis of osteolysis in multiple myeloma patientsNicola Giuliani, Simona Colla, Vittorio Rizzoli
Experimental Hematology|May 19, 2009
Osteogenic differentiation of mesenchymal stem cells in multiple myeloma: identification of potential therapeutic targetsNicola Giuliani, Marcellina Mangoni, Vittorio Rizzoli
Blood|August 19, 2006
Multiple myeloma bone disease: Pathophysiology of osteoblast inhibitionNicola Giuliani, Vittorio Rizzoli, G David Roodman
Haematologica|June 13, 2003
Angiopoietins expression by human myeloma cellsSimona Colla, Giovanni Roti, Vittorio Rizzoli, et al.
Leukemia & Lymphoma|December 29, 2004
Angiopoietin-1 and myeloma-induced angiogenesisNicola Giuliani, Simona Colla, Francesca Morandi, et al.
Haematologica|September 21, 2004
The RANK/RANK ligand system is involved in interleukin-6 and interleukin-11 up-regulation by human myeloma cells in the bone marrow microenvironmentNicola Giuliani, Simona Colla, Francesca Morandi, et al.
Current Pharmaceutical Biotechnology|December 16, 2006
Targeting pathways mediating bone diseaseNicola Giuliani, Francesca Morandi, Sara Tagliaferri, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Leukemia & Lymphoma|December 11, 2007
Myeloma cells and bone marrow osteoblast interactions: role in the development of osteolytic lesions in multiple myelomaNicola Giuliani, Vittorio Rizzoli
Experimental Hematology|August 17, 2004
New insight in the mechanism of osteoclast activation and formation in multiple myeloma: focus on the receptor activator of NF-kappaB ligand (RANKL)Nicola Giuliani, Simona Colla, Vittorio Rizzoli
Hematology (Amsterdam, Netherlands)|March 15, 2005
Angiogenic switch in multiple myelomaNicola Giuliani, Simona Colla, Vittorio Rizzoli
Acta Bio-Medica : Atenei Parmensis|March 31, 2005
Update on the pathogenesis of osteolysis in multiple myeloma patientsNicola Giuliani, Simona Colla, Vittorio Rizzoli
Experimental Hematology|May 19, 2009
Osteogenic differentiation of mesenchymal stem cells in multiple myeloma: identification of potential therapeutic targetsNicola Giuliani, Marcellina Mangoni, Vittorio Rizzoli
Blood|August 19, 2006
Multiple myeloma bone disease: Pathophysiology of osteoblast inhibitionNicola Giuliani, Vittorio Rizzoli, G David Roodman
Haematologica|June 13, 2003
Angiopoietins expression by human myeloma cellsSimona Colla, Giovanni Roti, Vittorio Rizzoli, et al.
Leukemia & Lymphoma|December 29, 2004
Angiopoietin-1 and myeloma-induced angiogenesisNicola Giuliani, Simona Colla, Francesca Morandi, et al.
Haematologica|September 21, 2004
The RANK/RANK ligand system is involved in interleukin-6 and interleukin-11 up-regulation by human myeloma cells in the bone marrow microenvironmentNicola Giuliani, Simona Colla, Francesca Morandi, et al.
Current Pharmaceutical Biotechnology|December 16, 2006
Targeting pathways mediating bone diseaseNicola Giuliani, Francesca Morandi, Sara Tagliaferri, et al.
Pageof 5